NCT03887299View on ClinicalTrials.gov

Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 18, 2019

Primary Completion Date

January 18, 2020

Study Completion Date

February 28, 2020

Conditions
Cesarean Section ComplicationsWound BreakdownWound InfectionSatisfactionSurgical Wound Infection
Interventions
COMBINATION_PRODUCT

ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG)

Dressing will be applied in the operating room at the end of case and be in place until postoperative day 7

OTHER

Standard Wound Care

Wound care will be administered as standard protocol in our institution

Trial Locations (1)

77555

Ashley Salazar, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03887299 - Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery | Biotech Hunter | Biotech Hunter